MENU
NURPF
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Neuren Pharmaceuticals (NURPF) Ownership - Who owns Neuren Pharmaceuticals?

Profile

Industry
N/A
Address
697 Burke Road
Phone
+61 390920480
Employees
11
Web
https://www.neurenpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.36B
P/E Ratio
16.41
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
140.69M
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
1.06 USD as % of share price

Fundamentals

NURPF
Capitalization
1.36B
P/E Ratio
16.41
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.06%
Revenue
141M
ROE
N/A
Book Value
N/A
P/B Ratio
6.13
Cash Flow
N/A
Earnings
0.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
108M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
56.98
Shares Held By Institutions
443M
Shares Outstanding - Current
130M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
-59.776
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
697 Burke Road
Phone
+61 390920480
Employees
11
Web
https://www.neurenpharma.com